This analysis offers a thorough examination of two prominent Emerging Markets Exchange Traded Funds, focusing on their holdings, performance, and strategic implications for investors. The Columbia EM Core ex-China ETF (XCEM) and the iShares MSCI Emerging Markets ETF (EEM) are evaluated, with a particular emphasis on their approaches to Chinese market exposure and the resulting portfolio compositions.
Emerging Markets ETF Showdown: XCEM and EEM Performance & Strategy
In mid-2023, a comparative study was conducted on several Emerging Markets (EM) Exchange Traded Funds, specifically those designed to operate without significant exposure to the Chinese market. This research highlighted the robust performance of these China-excluded funds when measured against a broader, less restricted EM ETF. The iShares MSCI Emerging Markets ETF, known by its ticker EEM, served as the benchmark for this comparison. Both the Columbia EM Core ex-China ETF (XCEM) and a peer China-free EM fund received favorable "Buy" ratings, underscoring their appeal in the then-current investment landscape.
A deep dive into the EEM reveals a portfolio heavily concentrated in Asian markets, with the information technology and financial sectors dominating its allocation. The fund's top twenty holdings represent a substantial 39% of its total assets, indicating a high degree of concentration in a select group of large-cap companies. This structure offers investors exposure to established market leaders within the emerging world.
Conversely, the XCEM ETF employs a distinctive strategy by explicitly excluding companies based in mainland China and Hong Kong. It aims to track an internally developed index that encompasses up to 700 companies. This index is constructed using a market-capitalization weighting methodology and undergoes rebalancing on a quarterly basis. This rigorous approach ensures a diversified exposure to emerging markets while deliberately avoiding the specific geopolitical and economic risks associated with China.
Recent global events, including new tariff announcements and evolving regulatory frameworks, have underscored the persistent uncertainties prevalent in the international trade and investment arena. These developments further bolster the rationale behind investment strategies that seek to limit or entirely remove exposure to the Chinese market within emerging market portfolios. The dynamic nature of these external factors reinforces the relevance and potential long-term benefits of ex-China EM strategies.
Despite its strategic advantages, one notable risk associated with investing in XCEM is its significant allocation to Taiwan Semiconductor. This concentration implies that the fund's performance could be substantially influenced by the fortunes of this single, albeit dominant, technology giant. However, even with this concentration risk, the XCEM retains its "Buy" recommendation, a rating consistent with prior assessments. This continued endorsement is predicated on its overall diversified approach and its insulation from direct Chinese market fluctuations. For investors who prefer to maintain exposure to China, the EEM is also recommended with a "Buy" rating, particularly given the current positive momentum favoring emerging market stocks globally.
As an observer of these investment vehicles, the persistent focus on China's role within emerging markets is striking. The market's segmentation into 'with China' and 'without China' strategies highlights a fundamental shift in how global investors perceive risk and opportunity in developing economies. It compels a re-evaluation of traditional emerging market definitions and encourages a more nuanced approach to portfolio construction, emphasizing the importance of adaptability and strategic foresight in a rapidly changing world.